Candida albicans is a commensal yeast fungus of the human oral, gastrointestinal, and
genital mucosal surfaces, and skin. Antibiotic-induced dysbiosis, iatrogenic …

Invasive candidiasis is an important fungal disease caused by Candida albicans and,
increasingly, non-albicans Candida pathogens. Invasive Candida infections originate most …

Background Rezafungin is a next-generation, once-a-week echinocandin in development
for the treatment of candidaemia and invasive candidiasis and for the prevention of invasive …

Background The incidence of candidemia in our hospital has been stable over an 18‐year
period (1.3 episodes per 1000 admissions). Since March 2020, we have observed an …

Antibiotics are a modifiable iatrogenic risk factor for the most common human nosocomial
fungal infection, invasive candidiasis, yet the underlying mechanisms remain elusive. We …

Increasing incidence of invasive fungal infections combined with a growing population of
immunocompromised hosts has created a rising need for antifungal agents. Isavuconazole …

Representatives of the Candida parapsilosis complex are important yeast species causing
human infections, including candidaemia as one of the leading diseases. This complex …

Emerging antimicrobial resistance and side effects associated with antibiotics overuse are
driving the need for the novel antimicrobial therapeutics with the natural compounds …

Emerging studies have highlighted the disproportionate role of Candida albicans in
influencing both early community assembly of the bacterial microbiome and dysbiosis during …

The fungus Candida albicans is a ubiquitous member of the human gut microbiota.
Hundreds or thousands of bacterial taxa reside together with this fungus in the intestine …